Literature DB >> 24073801

Factors affecting patient's perception of anticancer treatments side-effects: an observational study.

Stefania Russo1, Marika Cinausero, Lorenzo Gerratana, Claudia Bozza, Donatella Iacono, Pamela Driol, Laura Deroma, Roberta Sottile, Gianpiero Fasola, Fabio Puglisi.   

Abstract

BACKGROUND: Analysis of relative importance of side effects of anticancer therapy is extremely useful in the process of clinical decision making. There is evidence that patients' perception of the side effects of anticancer treatments changes over time.
OBJECTIVES: Aim of this study was to evaluate the cancer patients' perceptions of physical and non-physical side effects of contemporary anticancer therapy. Four hundred and sixty-four patients entered the study (153 men and 311 women). Participants were asked to rank their side effects in order of distress by using two sets of cards naming physical and non-physical effects, respectively. Influencing factors, including treatment and patient characteristics, were also analysed.
RESULTS: Patients ranked the non-physical side effect 'Affects my family or partner' first. 'Constantly tired' and 'Loss of hair' were ranked second and third, respectively. Significant differences from previous studies on this topic emerged. In particular, 'Vomiting', a predominant concern in previous studies, almost disappeared, whereas 'Nausea' and 'Loss of hair' remained important side effects in the patients' perception. Interestingly, marital status was predominant in driving patients' perception, being associated with several side effects ('Constantly tired', 'Loss of appetite', 'Affects my work/Home duties', 'Affects my social activities', 'Infertility'). Other significant factors influencing patient's perception of side effects included age, disease characteristics and ongoing anticancer therapy.
CONCLUSIONS: This study provided information on current status of patients' perceptions of side effects of anticancer treatment. These results could be used in pre-treatment patient education and counselling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24073801     DOI: 10.1517/14740338.2013.830710

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  9 in total

1.  Positive effects of acupressure bands combined with relaxation music/instructions on patients most at risk for chemotherapy-induced nausea.

Authors:  Anita R Peoples; Eva Culakova; Charles E Heckler; Michelle Shayne; Tracey L O'Connor; Jeffrey J Kirshner; Peter W Bushunow; Gary R Morrow; Joseph A Roscoe
Journal:  Support Care Cancer       Date:  2019-03-30       Impact factor: 3.603

Review 2.  Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV).

Authors:  Noha Rashad; Omar Abdel-Rahman
Journal:  Drug Des Devel Ther       Date:  2017-03-24       Impact factor: 4.162

3.  A qualitative study investigating chemotherapy-induced nausea as a symptom cluster.

Authors:  Ian N Olver; Jaklin A Eliott; Bogda Koczwara
Journal:  Support Care Cancer       Date:  2014-05-08       Impact factor: 3.603

4.  Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy.

Authors:  Martin Chasen; Laszlo Urban; Ian Schnadig; Bernardo Rapoport; Dan Powers; Sujata Arora; Rudolph Navari; Lee Schwartzberg; Cesare Gridelli
Journal:  Support Care Cancer       Date:  2016-08-24       Impact factor: 3.603

5.  Oncologist perspectives on chemotherapy-induced nausea and vomiting (CINV) management and outcomes: A quantitative market research-based survey.

Authors:  Matti Aapro; Pierfrancesco Ruffo; Roger Panteri; Stefano Costa; Vittoria Piovesana
Journal:  Cancer Rep (Hoboken)       Date:  2018-10-09

Review 6.  Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert Panel.

Authors:  Giampaolo Bianchini; Grazia Arpino; Laura Biganzoli; Sara Lonardi; Fabio Puglisi; Daniele Santini; Matteo Lambertini; Giovanni Pappagallo
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

Review 7.  Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy.

Authors:  Mary Lou Affronti; Joseph Bubalo
Journal:  Cancer Manag Res       Date:  2014-09-05       Impact factor: 3.989

8.  The Most Common Side Effects Experienced by Patients Were Receiving First Cycle of Chemotherapy.

Authors:  İnsaf Altun; Alper Sonkaya
Journal:  Iran J Public Health       Date:  2018-08       Impact factor: 1.429

9.  Psychological predictors of chemotherapy-induced nausea in women with breast cancer: Expectancies and perceived susceptibility.

Authors:  Elise J Devlin; Hayley S Whitford; Anita R Peoples; Gary R Morrow; Sreedhar Katragadda; Jeffrey K Giguere; Bilal Naqvi; Joseph Roscoe
Journal:  Eur J Cancer Care (Engl)       Date:  2021-07-29       Impact factor: 2.328

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.